This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Body Organ Biomedical Corp.. Active years: 2019-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2020
Title: Ta-Wei Su: Innovator in Tissue Repair Technology
Introduction
Ta-Wei Su is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biomedical engineering, particularly in the development of innovative tissue repair materials. With a total of 2 patents to his name, Su's work is paving the way for advancements in medical treatments.
Latest Patents
One of Ta-Wei Su's latest patents focuses on a tissue repair material derived from fish skin. This innovative material is designed to be used as a patch, cover, carrier, scaffold, implant, or reagent in various tissues. The unique properties of this tissue repair material include collagen, which enhances the healing process of wounded tissues. Additionally, it has been found that the factors of terrestrial animal transmitted diseases, caused by viruses, do not survive on this fish skin-derived material. This makes it a safer option for medical applications.
Career Highlights
Ta-Wei Su is currently associated with Body Organ Biomedical Corp., where he continues to develop groundbreaking technologies in the field of tissue engineering. His work is characterized by a commitment to improving patient outcomes through innovative solutions.
Collaborations
Su collaborates with notable colleagues, including Horng-Ji Lai and Min-Chang Huang, who contribute to the research and development efforts at Body Organ Biomedical Corp. Their combined expertise enhances the potential for successful innovations in biomedical applications.
Conclusion
Ta-Wei Su's contributions to tissue repair technology exemplify the impact of innovative thinking in the medical field. His work not only addresses critical healthcare needs but also sets a foundation for future advancements in tissue engineering.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile